Complications Associated with the Use of Urokinase and Recombinant Tissue Plasminogen Activator for Catheter-directed Peripheral Arterial and Venous Thrombolysis
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 11 (3) , 295-298
- https://doi.org/10.1016/s1051-0443(07)61420-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Catheter-directed Thrombolysis for Lower Extremity Deep Venous Thrombosis: Report of a National Multicenter RegistryRadiology, 1999
- A Comparison of Recombinant Urokinase with Vascular Surgery as Initial Treatment for Acute Arterial Occlusion of the LegsNew England Journal of Medicine, 1998
- Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion—A Consensus DocumentThe American Journal of Cardiology, 1998
- Thrombolysis for acute deep vein thrombosisBritish Journal of Surgery, 1996
- Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE TrialAnnals of Surgery, 1994
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.Radiology, 1990
- Use and limitations of thrombolytic therapy in the treatment of peripheral arterial ischemia: Results of a multi-institutional questionnaireJournal of Vascular Surgery, 1987
- Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosisThe American Journal of Medicine, 1984